View the full Tomography list with 24 results.

Matching Calls

• Фаза 1, включваща клинични изпитвания при хора за тестване на лекарства, ръководени от биомаркери, или мултимодални интервенции за лечение на пациенти с редки или много редки ракови заболявания или ракови подтипове

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fáze 1 zahrnující klinické studie prováděné první osobou za účelem testování léčivých přípravků řízených biomarkerem nebo multimodálních léčebných intervencí u pacientů se vzácnými nebo velmi vzácnými nádorovými onemocněními nebo podtypy nádorových onemocnění

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fase 1, herunder første kliniske forsøg på mennesker med henblik på at teste biomarkørstyrede lægemidler eller multimodale behandlingsinterventioner for patienter med sjældne eller meget sjældne kræftformer eller kræftsubtyper

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Phase 1, einschließlich klinischer Studien zum ersten Mal am Menschen, um biomarkergeführte Arzneimittel oder multimodale Behandlungsinterventionen für Patienten mit seltenen oder sehr seltenen Krebsarten oder Krebssubtypen zu testen

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Φάση 1, συμπεριλαμβανομένων των πρώτων στον άνθρωπο κλινικών δοκιμών για τη δοκιμή φαρμάκων καθοδηγούμενων από βιοδείκτες ή πολυτροπικών θεραπευτικών παρεμβάσεων για ασθενείς με σπάνιους ή πολύ σπάνιους καρκίνους ή υποτύπους καρκίνου

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fase 1, incluidos los primeros ensayos clínicos en humanos para probar medicamentos guiados por biomarcadores o intervenciones de tratamiento multimodal para pacientes con cánceres o subtipos de cáncer raros o muy raros

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• etapp, mis hõlmab esimese inimese kliinilisi uuringuid, et katsetada biomarkeril põhinevaid ravimeid või multimodaalseid raviprotseduure harvaesinevate või väga harvaesinevate vähivormide või vähi alatüüpidega patsientidel

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Vaihe 1, mukaan lukien ensimmäiset kliiniset tutkimukset, joissa testataan biomerkkiaineohjattuja lääkkeitä tai multimodaalisia hoitotoimenpiteitä harvinaisia tai erittäin harvinaisia syöpiä tai syövän alatyyppejä sairastaville potilaille

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Phase 1 incluant les premiers essais cliniques sur l'homme pour tester des médicaments guidés par des biomarqueurs ou des interventions de traitement multimodal chez des patients atteints de cancers ou de sous-types de cancer rares ou très rares

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Céim 1 lena n-áirítear trialacha cliniciúla duine le duine chun cógais faoi threoir bithmharcóra nó idirghabhálacha cóireála ilmhódacha a thástáil d’othair a bhfuil ailsí nó fochineálacha ailse neamhchoitianta nó an-annamh orthu

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Faza 1., uključujući prva klinička ispitivanja na ljudima za ispitivanje lijekova na temelju biomarkera ili multimodalne intervencije liječenja za bolesnike s rijetkim ili vrlo rijetkim vrstama raka ili podtipovima raka

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• 1. szakasz, beleértve a biomarkerek által vezérelt gyógyszerek vagy multimodális kezelési beavatkozások tesztelésére irányuló első humán klinikai vizsgálatokat ritka vagy nagyon ritka daganatos betegségekben vagy daganatos altípusokban szenvedő betegeknél

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fase 1, compresi i primi studi clinici sull'uomo per testare medicinali guidati da biomarcatori o interventi terapeutici multimodali per pazienti con tumori o sottotipi di cancro rari o molto rari

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• 1 etapas, įskaitant pirmojo žmogaus klinikinius tyrimus, kuriais siekiama išbandyti biologiniais žymenimis grindžiamus vaistus arba daugiarūšio gydymo intervencines priemones pacientams, sergantiems retomis arba labai retomis vėžio formomis arba vėžio potipiais

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• fāze, kas ietver pirmos klīniskos izmēģinājumus ar cilvēkiem, lai pārbaudītu biomarķieru vadītas zāles vai multimodālas ārstēšanas intervences pacientiem ar retiem vai ļoti retiem vēža veidiem vai vēža apakštipiem

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fażi 1 li tinkludi provi kliniċi tal-ewwel bniedem biex jiġu ttestjati mediċini ggwidati minn bijomarkatur jew interventi ta’ trattament multimodali għal pazjenti b’kanċers jew sottotipi ta’ kanċer rari jew rari ħafna

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fase 1 met inbegrip van eerste klinische proeven bij de mens om biomarkergeleide geneesmiddelen of multimodale behandelingsinterventies te testen voor patiënten met zeldzame of zeer zeldzame vormen van kanker of subtypes van kanker

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Faza 1 obejmująca pierwsze badania kliniczne z udziałem ludzi w celu przetestowania leków kierowanych biomarkerami lub interwencji w leczeniu multimodalnym u pacjentów z rzadkimi lub bardzo rzadkimi nowotworami lub podtypami raka

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fase 1, incluindo ensaios clínicos em seres humanos para testar medicamentos guiados por biomarcadores ou intervenções de tratamento multimodal em doentes com cancros raros ou muito raros ou subtipos de cancro

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Faza 1, inclusiv primele studii clinice la om pentru testarea medicamentelor ghidate de biomarkeri sau a intervențiilor de tratament multimodal pentru pacienții cu forme de cancer sau subtipuri de cancer rare sau foarte rare

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fáza 1 vrátane prvého klinického skúšania na ľuďoch zameraného na testovanie liekov riadených biomarkermi alebo multimodálnych liečebných zásahov u pacientov so zriedkavými alebo veľmi zriedkavými druhmi rakoviny alebo podtypmi rakoviny

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Faza 1, vključno s prvimi kliničnimi preskušanji na ljudeh za preskušanje zdravil, vodenih z biološkimi označevalci, ali večmodalnih ukrepov zdravljenja za bolnike z redkimi ali zelo redkimi vrstami raka ali podtipi raka

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fas 1 inklusive kliniska första-i-mänskliga prövningar för att testa biomarkörstyrda läkemedel eller multimodala behandlingsinterventioner för patienter med sällsynta eller mycket sällsynta cancerformer eller cancersubtyper

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU